SAMHD1 Reduces Efficiency of Nucleoside Analog Ara-C Against AML Cells
Description
This template was adapted from the original submission. Edits were made to enhance scientific accuracy, optimal usability and/or to meet industry-leading design standards for science communication.
This figure illustrates how SAMHD1, a dNTP hydrolase, reduces the efficiency of nucleoside analog, Ara-C, against acute myeloid leukemia (AML) cells. Once inside the AML cells, the inactive Ara-C gets triphosphorylated (Ara-CTP). In SAMHD1-low AML cells, Ara-CTP inhibits DNA replication, leading to apoptosis. In SAMHD1-high AML cells, Ara-CTP is recognized as a SAMHD1 substrate and is converted back to inactive Ara-C. Here, DNA replication progresses and the cells are protected from apoptosis.
Acknowledgements
References
Schneider, C. et. al.. (2017) SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.. Nature Medicine. https://www.nature.com/articles/nm.4255
Get started with this template for freeDon’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures